MIFH
TWST icon

Migdal Insurance & Financial Holdings’s Twist Bioscience TWST Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-5,543
Closed -$687K – 673
2021
Q1 		$687K Buy
5,543
+3,440
+164% +$522K 0.01% 285
2020
Q4 		$297K Buy
+2,103
New +$233K ﹤0.01% 264

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Migdal Insurance & Financial Holdings's TWST Position: Q2 2021 in Review

Migdal Insurance & Financial Holdings sold out of Twist Bioscience (TWST) in Q2 2021, closing a stake of 5,543 shares — an estimated $687K sold.

Migdal Insurance & Financial Holdings first reported a position in TWST in Q4 2020 and held it in 2 quarters. The position peaked at $687K in Q1 2021. 245 funds tracked by Wall St. Rank hold TWST as of Q2 2021.

  • Migdal Insurance & Financial Holdings reported no remaining Twist Bioscience position as of Q2 2021 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 5,543 Twist Bioscience shares in Q2 2021, an estimated $687K.
  • Migdal Insurance & Financial Holdings first reported a position in Twist Bioscience in Q4 2020 and held it in 2 quarters.
  • Migdal Insurance & Financial Holdings's Twist Bioscience position peaked at $687K in Q1 2021.
  • 245 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2021.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q2 2021, filed 4 Aug 2021.